{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:05:17Z","timestamp":1778054717679,"version":"3.51.4"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701082"],"award-info":[{"award-number":["81701082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Hebei Province of China","award":["H2017307012"],"award-info":[{"award-number":["H2017307012"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jns.2019.07.015","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T23:17:29Z","timestamp":1563232649000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Homocysteine: A modifiable culprit of cognitive impairment for us to conquer?"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-0652","authenticated-orcid":false,"given":"Yifan","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyuan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9704","key":"10.1016\/j.jns.2019.07.015_bb0005","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(09)61829-8","article-title":"Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10\/66 Dementia Research Group population-based survey","volume":"374","author":"Sousa","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1504327","article-title":"Incidence of dementia over three decades in the Framingham Heart Study","volume":"374","author":"Satizabal","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"14","key":"10.1016\/j.jns.2019.07.015_bb0020","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jns.2019.07.015_bb0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0030","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am. J. Pathol."},{"issue":"9203","key":"10.1016\/j.jns.2019.07.015_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(99)93019-2","article-title":"Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men","volume":"355","author":"Chambers","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2019.07.015_bb0040","first-page":"1632","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Farhadi","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jns.2019.07.015_bb0045","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s12035-015-9226-y","article-title":"Plasma homocysteine levels predict the risk of acute cerebral infarction in patients with carotid artery lesions","volume":"53","author":"Wu","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"9455","key":"10.1016\/j.jns.2019.07.015_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jns.2019.07.015_bb0055","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jns.2019.07.015_bb0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajcn\/77.3.668","article-title":"Homocysteine and cognitive function in healthy elderly community dwellers in Italy","volume":"77","author":"Ravaglia","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/01.WNL.0000129986.19019.5D","article-title":"Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study","volume":"63","author":"Wright","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2019.07.015_bb0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/01.WNL.0000032494.05619.93","article-title":"Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study","volume":"59","author":"Prins","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ajcn\/78.3.441","article-title":"Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging","volume":"78","author":"Miller","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.jns.2019.07.015_bb0085","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/ajcn\/82.4.866","article-title":"Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study","volume":"82","author":"Mooijaart","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.jns.2019.07.015_bb0090","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","article-title":"Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease","volume":"55","author":"Clarke","year":"1998","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","article-title":"Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia","volume":"80","author":"Quadri","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jns.2019.07.015_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neubiorev.2016.08.014","article-title":"Homocysteine and cognition: a systematic review of 111 studies","volume":"69","author":"Setien-Suero","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","article-title":"Homocysteine and folate as risk factors for dementia and Alzheimer disease","volume":"82","author":"Ravaglia","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ajcn\/85.2.511","article-title":"Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging","volume":"85","author":"Haan","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2796.2011.02484.x","article-title":"Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study","volume":"271","author":"Hooshmand","year":"2012","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ajcn\/82.3.627","article-title":"High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study","volume":"82","author":"Tucker","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"16","key":"10.1016\/j.jns.2019.07.015_bb0125","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e3181f88162","article-title":"Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study","volume":"75","author":"Hooshmand","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3233\/JAD-150977","article-title":"Homocysteine and Alzheimer\u2019s disease: evidence for a causal link from mendelian randomization","volume":"52","author":"Hu","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-180013","article-title":"Which risk factors causally influence dementia? A systematic review of mendelian randomization studies","volume":"64","author":"Kuzma","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2019.07.015_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.09.033","article-title":"Genetic influence of plasma homocysteine on Alzheimer\u2019s disease","volume":"62","author":"Roostaei","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2019.07.015_bb0145","article-title":"Modifiable pathways in Alzheimer\u2019s disease: mendelian randomisation analysis","volume":"359","author":"Larsson","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10545-010-9151-1","article-title":"The homocysteine controversy","volume":"34","author":"Smulders","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.jns.2019.07.015_bb0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2362.2010.02464.x","article-title":"Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients","volume":"41","author":"Shimomura","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.jns.2019.07.015_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175102","article-title":"Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: an exploratory pilot study","volume":"12","author":"Maesato","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jns.2019.07.015_bb0165","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1017\/S1041610210000499","article-title":"Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension","volume":"22","author":"Firbank","year":"2010","journal-title":"Int. Psychogeriatr."},{"issue":"Pt 1","key":"10.1016\/j.jns.2019.07.015_bb0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030891","article-title":"Homocysteine increases Tau Phosphorylation, truncation and oligomerization","volume":"19","author":"Shirafuji","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0180","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.24145","article-title":"Homocysteine exacerbates beta-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles","volume":"75","author":"Li","year":"2014","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116330","article-title":"Microstructural white matter tissue characteristics are modulated by homocysteine: a diffusion tensor imaging study","volume":"10","author":"Hsu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12883-017-0970-7","article-title":"Effects of homocysteine on white matter diffusion parameters in Alzheimer\u2019s disease","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/STROKEAHA.115.011545","article-title":"Association of MTHFR C677T genotype with ischemic stroke is confined to cerebral small vessel disease subtype","volume":"47","author":"Rutten-Jacobs","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jns.2019.07.015_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000000168","article-title":"Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study","volume":"82","author":"Kloppenborg","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db14-0784","article-title":"Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via mu-calpain activation","volume":"64","author":"Cheng","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2019.07.015_bb0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.redox.2018.09.021","article-title":"Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis","volume":"20","author":"Wu","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2015.07.021","article-title":"ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels","volume":"242","author":"Wang","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2019.07.015_bb0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.reprotox.2017.02.011","article-title":"Homocysteine-induced changes in cell proliferation and differentiation in the chick embryo spinal cord: implications for mechanisms of neural tube defects (NTD)","volume":"69","author":"Kobus-Bianchini","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.jns.2019.07.015_bb0225","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2011-02-338269","article-title":"Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions","volume":"118","author":"Beard","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jns.2019.07.015_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081196","article-title":"Homocysteine aggravates cortical neural cell injury through neuronal autophagy overactivation following rat cerebral ischemia-reperfusion","volume":"17","author":"Zhao","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2019.07.015_bb0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroscience.2014.09.078","article-title":"Homocysteine and cytosolic GSH depletion induce apoptosis and oxidative toxicity through cytosolic calcium overload in the hippocampus of aged mice: involvement of TRPM2 and TRPV1 channels","volume":"284","author":"Ovey","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/abbi.1997.0246","article-title":"Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene","volume":"345","author":"Sunden","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2019.07.015_bb0250","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbadis.2015.11.015","article-title":"Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID)","volume":"1862","author":"Hainsworth","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.jns.2019.07.015_bb0255","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0895-4356(00)00341-3","article-title":"The homocysteine distribution: (mis)judging the burden","volume":"54","author":"de Bree","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.jns.2019.07.015_bb0260","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood.V91.11.4158","volume":"91","author":"Girelli","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jns.2019.07.015_bb0265","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1182\/blood.V101.7.2483","article-title":"Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults","volume":"101","author":"Kluijtmans","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jns.2019.07.015_bb0270","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/jclinpath-2018-205048","article-title":"Laboratory assessment of folate (vitamin B9) status","volume":"71","author":"Sobczynska-Malefora","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ageing\/afg109","article-title":"Vitamin B12 and folate deficiency in later life","volume":"33","author":"Clarke","year":"2004","journal-title":"Age Ageing"},{"key":"10.1016\/j.jns.2019.07.015_bb0280","series-title":"Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","year":"1998"},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2016.19438","article-title":"Folic acid supplementation for the prevention of neural tube defects: US preventive services task force recommendation statement","volume":"317","author":"Force","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0290","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcn\/86.3.718","article-title":"Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004","volume":"86","author":"Pfeiffer","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"suppl_4","key":"10.1016\/j.jns.2019.07.015_bb0295","doi-asserted-by":"crossref","first-page":"1995S","DOI":"10.1093\/jn\/nxy201","article-title":"Biomarkers of nutrition for development (BOND): vitamin B-12 review","volume":"148","author":"Allen","year":"2018","journal-title":"J. Nutr."},{"key":"10.1016\/j.jns.2019.07.015_bb0300","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1038\/nrdp.2017.40","article-title":"Vitamin B12 deficiency","volume":"3","author":"Green","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jns.2019.07.015_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12937-015-0006-3","article-title":"Folate, vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center","author":"Barnabe","year":"2015","journal-title":"Nutr. J."},{"issue":"5","key":"10.1016\/j.jns.2019.07.015_bb0310","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ajcn\/87.5.1446","article-title":"Plasma pyridoxal 5\u2032-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004","volume":"87","author":"Morris","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/jf60191a037","article-title":"Vitamin B6 antagonists of natural origin","volume":"22","author":"Klosterman","year":"1974","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0320","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3945\/jn.115.219378","article-title":"A Vitamin B-6 antagonist from flaxseed perturbs amino acid metabolism in moderately Vitamin B-6-deficient male rats","volume":"146","author":"Mayengbam","year":"2016","journal-title":"J. Nutr."},{"issue":"2\u20133","key":"10.1016\/j.jns.2019.07.015_bb0325","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","article-title":"B6-responsive disorders: a model of vitamin dependency","volume":"29","author":"Clayton","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2019.07.015_bb0330","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/clinchem\/46.8.1065","article-title":"Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism","volume":"46","author":"Hustad","year":"2000","journal-title":"Clin. Chem."},{"issue":"5A","key":"10.1016\/j.jns.2019.07.015_bb0335","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1079\/PHN2001188","article-title":"The North\/South ireland food consumption survey: vitamin intakes in 18-64-year-old adults","volume":"4","author":"O\u2019Brien","year":"2001","journal-title":"Publ. Health Nutr."},{"issue":"4","key":"10.1016\/j.jns.2019.07.015_bb0340","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/pr.54.4.599","article-title":"Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease","volume":"54","author":"De Bree","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.jns.2019.07.015_bb0345","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/nutrit\/nuv022","article-title":"Assessing the association between homocysteine and cognition: reflections on Bradford Hill, meta-analyses, and causality","volume":"73","author":"McCaddon","year":"2015","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2003.01154.x","article-title":"Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia","volume":"254","author":"Clarke","year":"2003","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0355","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/ajcn\/82.6.1320","article-title":"Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease","volume":"82","author":"Stott","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"26","key":"10.1016\/j.jns.2019.07.015_bb0360","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1056\/NEJMoa054025","article-title":"A controlled trial of homocysteine lowering and cognitive performance","volume":"354","author":"McMahon","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9557","key":"10.1016\/j.jns.2019.07.015_bb0365","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","article-title":"Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial","volume":"369","author":"Durga","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jns.2019.07.015_bb0370","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jns.2019.07.015_bb0375","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/WNL.0b013e3181f962c4","article-title":"Vitamins B(12), B(6), and folic acid for cognition in older men","volume":"75","author":"Ford","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clnu.2010.12.004","article-title":"A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people","volume":"30","author":"Kwok","year":"2011","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0385","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.jns.2019.07.015_bb0390","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5912146","article-title":"Folic acid supplementation mitigates Alzheimer\u2019s disease by reducing inflammation: a randomized controlled trial","volume":"2016","author":"Chen","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0395","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.clnu.2016.10.018","article-title":"A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12","volume":"36","author":"Kwok","year":"2017","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jns.2019.07.015_bb0400","article-title":"Effects of folic acid supplementation on cognitive function and Abeta-related biomarkers in mild cognitive impairment: a randomized controlled trial","author":"Ma","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.jns.2019.07.015_bb0405","doi-asserted-by":"crossref","first-page":"37486","DOI":"10.1038\/srep37486","article-title":"Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jns.2019.07.015_bb0410","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/gerona\/glv183","article-title":"Effects of 6-month folic acid supplementation on cognitive function and blood biomarkers in mild cognitive impairment: a randomized controlled trial in China","volume":"71","author":"Ma","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0415","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7326\/M17-1530","article-title":"Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical alzheimer-type dementia: a systematic review","volume":"168","author":"Butler","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-2009-0971","article-title":"Methodological issues in primary prevention trials for neurodegenerative dementia","volume":"16","author":"Andrieu","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"19","key":"10.1016\/j.jns.2019.07.015_bb0425","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0430","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.108.180190","article-title":"Is H2S a stinky remedy for atherosclerosis?","volume":"29","author":"Wang","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.jns.2019.07.015_bb0435","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/ndt\/12.8.1622","article-title":"Abnormal cyanide metabolism in uraemic patients","volume":"12","author":"Koyama","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"issue":"23","key":"10.1016\/j.jns.2019.07.015_bb0440","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1001\/jama.2011.1834","article-title":"Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses","volume":"306","author":"Spence","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0445","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.clnu.2017.03.022","article-title":"High folate and low vitamin B12 status during pregnancy is associated with gestational diabetes mellitus","volume":"37","author":"Lai","year":"2018","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0450","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3945\/ajcn.112.056382","article-title":"High folate and low vitamin B-12 intakes during pregnancy are associated with small-for-gestational age infants in South Indian women: a prospective observational cohort study","volume":"98","author":"Dwarkanath","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.jns.2019.07.015_bb0455","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1532-5415.2012.04076.x","article-title":"Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the framingham heart study","volume":"60","author":"Morris","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0460","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3945\/ajcn.2009.28671","article-title":"Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors","volume":"91","author":"Morris","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0465","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.2008.26947C","article-title":"Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency","volume":"89","author":"Selhub","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"16","key":"10.1016\/j.jns.2019.07.015_bb0470","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0475","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.ATV.20.6.1557","article-title":"Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia","volume":"20","author":"Boger","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"13","key":"10.1016\/j.jns.2019.07.015_bb0480","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.2011.383","article-title":"A potential design flaw of randomized trials of vitamin supplements","volume":"305","author":"Morris","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0485","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3945\/ajcn.113.076349","article-title":"Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals","volume":"100","author":"Clarke","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"23","key":"10.1016\/j.jns.2019.07.015_bb0490","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jns.2019.07.015_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jns.2019.07.015_bb0500","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12603-017-0989-x","article-title":"Cross-sectional associations of total plasma homocysteine with cortical beta-amyloid independently and as a function of omega 3 polyunsaturated fatty acid status in older adults at risk of dementia","volume":"21","author":"Hooper","year":"2017","journal-title":"J. Nutr. Health Aging"},{"issue":"1","key":"10.1016\/j.jns.2019.07.015_bb0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3945\/ajcn.114.103283","article-title":"Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial","volume":"102","author":"Jerneren","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0510","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-150777","article-title":"Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment","volume":"50","author":"Oulhaj","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2019.07.015_bb0515","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neubiorev.2018.10.022","article-title":"Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: a systematic review","volume":"95","author":"Solfrizzi","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.jns.2019.07.015_bb0520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1474-4422(12)70091-1","article-title":"Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jns.2019.07.015_bb0525","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2019.07.015_bb0530","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STROKEAHA.114.006927","article-title":"Differential effect of B-vitamin therapy by antiplatelet use on risk of recurrent vascular events after stroke","volume":"46","author":"Arshi","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2019.07.015_bb0535","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1747493015616512","article-title":"Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: A meta-analysis","volume":"11","author":"Park","year":"2016","journal-title":"Int. J. Stroke"}],"updated-by":[{"DOI":"10.1016\/j.jns.2019.116481","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000}}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19303181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19303181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T23:58:29Z","timestamp":1721519909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19303181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":107,"alternative-id":["S0022510X19303181"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.015","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jns.2019.116481","asserted-by":"object"}]},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine: A modifiable culprit of cognitive impairment for us to conquer?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}